-DOCSTART- -X- O
Interferon-inducible -X- _ B-Intervention
transmembrane -X- _ I-Intervention
proteins -X- _ I-Intervention
1 -X- _ I-Intervention
, -X- _ I-Intervention
2 -X- _ I-Intervention
, -X- _ I-Intervention
and -X- _ I-Intervention
3 -X- _ I-Intervention
( -X- _ I-Intervention
IFITM -X- _ I-Intervention
1,2 -X- _ I-Intervention
, -X- _ I-Intervention
and -X- _ I-Intervention
3 -X- _ I-Intervention
) -X- _ I-Intervention
are -X- _ O
viral -X- _ O
restriction -X- _ O
factors -X- _ O
that -X- _ O
mediate -X- _ O
cellular -X- _ O
resistance -X- _ O
to -X- _ O
several -X- _ O
viruses. -X- _ O
We -X- _ O
have -X- _ O
genotyped -X- _ O
a -X- _ O
possible -X- _ B-Intervention
splice- -X- _ I-Intervention
site -X- _ I-Intervention
altering -X- _ I-Intervention
single-nucleotide -X- _ I-Intervention
polymorphism -X- _ I-Intervention
( -X- _ I-Intervention
rs12252 -X- _ I-Intervention
) -X- _ I-Intervention
in -X- _ I-Intervention
the -X- _ I-Intervention
IFITM3 -X- _ I-Intervention
gene -X- _ I-Intervention
in -X- _ O
34 -X- _ B-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
H1N1 -X- _ I-Patient
influenza -X- _ I-Patient
and -X- _ I-Patient
severe -X- _ I-Patient
pneumonia -X- _ I-Patient
, -X- _ I-Patient
and -X- _ I-Patient
> -X- _ I-Patient
5000 -X- _ I-Patient
individuals -X- _ I-Patient
comprising -X- _ I-Patient
patients -X- _ I-Patient
with -X- _ I-Patient
community-acquired -X- _ I-Patient
mild -X- _ I-Patient
lower -X- _ I-Patient
respiratory -X- _ I-Patient
tract -X- _ I-Patient
infection -X- _ I-Patient
and -X- _ I-Patient
matched -X- _ I-Patient
controls -X- _ I-Patient
of -X- _ I-Patient
Caucasian -X- _ I-Patient
ancestry. -X- _ I-Patient
We -X- _ O
found -X- _ O
evidence -X- _ O
of -X- _ O
an -X- _ O
association -X- _ B-Outcome
between -X- _ I-Outcome
rs12252 -X- _ I-Outcome
rare -X- _ I-Outcome
allele -X- _ I-Outcome
homozygotes -X- _ I-Outcome
and -X- _ I-Outcome
susceptibility -X- _ I-Outcome
to -X- _ I-Outcome
mild -X- _ I-Outcome
influenza -X- _ I-Outcome
( -X- _ I-Outcome
in -X- _ I-Outcome
patients -X- _ I-Outcome
attending -X- _ I-Outcome
primary -X- _ I-Outcome
care -X- _ I-Outcome
) -X- _ I-Outcome
but -X- _ I-Outcome
could -X- _ I-Outcome
not -X- _ I-Outcome
confirm -X- _ I-Outcome
a -X- _ I-Outcome
previously -X- _ I-Outcome
reported -X- _ I-Outcome
association -X- _ I-Outcome
between -X- _ I-Outcome
this -X- _ I-Outcome
single-nucleotide -X- _ I-Outcome
polymorphism -X- _ I-Outcome
and -X- _ I-Outcome
susceptibility -X- _ I-Outcome
to -X- _ I-Outcome
severe -X- _ I-Outcome
H1N1 -X- _ I-Outcome
infection -X- _ I-Outcome
. -X- _ O

